Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Differential expression of TGF-β superfamily members and role of Smad1/5/9-signalling in chondral versus endochondral chondrocyte differentiation.

Dexheimer V, Gabler J, Bomans K, Sims T, Omlor G, Richter W.

Sci Rep. 2016 Nov 16;6:36655. doi: 10.1038/srep36655.

2.

Increased bone formation in a rabbit long-bone defect model after single local and single systemic application of erythropoietin.

Omlor GW, Kleinschmidt K, Gantz S, Speicher A, Guehring T, Richter W.

Acta Orthop. 2016 Aug;87(4):425-31. doi: 10.1080/17453674.2016.1198200. Epub 2016 Jun 27.

3.

Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy--a randomized trial.

Rief H, Omlor G, Akbar M, Bruckner T, Rieken S, Förster R, Schlampp I, Welzel T, Bostel T, Roth HJ, Debus J.

BMC Cancer. 2016 Mar 17;16:231. doi: 10.1186/s12885-016-2278-1.

4.

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function.

Morgan WJ, VanDevanter DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW; Scientific Advisory Group.; Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2016 Feb;169:116-21.e2. doi: 10.1016/j.jpeds.2015.08.042. Epub 2015 Sep 19.

PMID:
26388208
5.

Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.

Sanders DB, Emerson J, Ren CL, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group..

Ann Am Thorac Soc. 2015 Aug;12(8):1170-6. doi: 10.1513/AnnalsATS.201504-198OC.

6.

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Ströbel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, Liersch T; German Rectal Cancer Study Group..

Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.

PMID:
26189067
7.

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group..

Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9.

PMID:
26061914
8.

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group.; TRANSPORT Study Group..

N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17.

9.

Clinical long-term outcome, technical success, and cost analysis of radiofrequency ablation for the treatment of osteoblastomas and spinal osteoid osteomas in comparison to open surgical resection.

Weber MA, Sprengel SD, Omlor GW, Lehner B, Wiedenhöfer B, Kauczor HU, Rehnitz C.

Skeletal Radiol. 2015 Jul;44(7):981-93. doi: 10.1007/s00256-015-2139-z. Epub 2015 Apr 25.

PMID:
25910709
10.

Loss of notochordal cell phenotype in 3D-cell cultures: implications for disc physiology and disc repair.

Omlor GW, Nerlich AG, Tirlapur UK, Urban JP, Guehring T.

Arch Orthop Trauma Surg. 2014 Dec;134(12):1673-81. doi: 10.1007/s00402-014-2097-2. Epub 2014 Oct 28.

PMID:
25348151
11.

The effect of resistance training during radiotherapy on spinal bone metastases in cancer patients - a randomized trial.

Rief H, Petersen LC, Omlor G, Akbar M, Bruckner T, Rieken S, Haefner MF, Schlampp I, Förster R, Debus J, Welzel T; German Bone Research Group..

Radiother Oncol. 2014 Jul;112(1):133-9. doi: 10.1016/j.radonc.2014.06.008. Epub 2014 Jul 7.

PMID:
25012645
12.

Quality of life and fatigue of patients with spinal bone metastases under combined treatment with resistance training and radiation therapy- a randomized pilot trial.

Rief H, Akbar M, Keller M, Omlor G, Welzel T, Bruckner T, Rieken S, Häfner MF, Schlampp I, Gioules A, Debus J.

Radiat Oncol. 2014 Jul 7;9:151. doi: 10.1186/1748-717X-9-151.

13.

Pain response of resistance training of the paravertebral musculature under radiotherapy in patients with spinal bone metastases--a randomized trial.

Rief H, Welzel T, Omlor G, Akbar M, Bruckner T, Rieken S, Haefner MF, Schlampp I, Gioules A, Debus J.

BMC Cancer. 2014 Jul 5;14:485. doi: 10.1186/1471-2407-14-485.

14.

Short-term follow-up of disc cell therapy in a porcine nucleotomy model with an albumin-hyaluronan hydrogel: in vivo and in vitro results of metabolic disc cell activity and implant distribution.

Omlor GW, Fischer J, Kleinschmitt K, Benz K, Holschbach J, Brohm K, Anton M, Guehring T, Richter W.

Eur Spine J. 2014 Sep;23(9):1837-47. doi: 10.1007/s00586-014-3314-y. Epub 2014 May 7.

PMID:
24801573
15.

Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial.

Rief H, Omlor G, Akbar M, Welzel T, Bruckner T, Rieken S, Haefner MF, Schlampp I, Gioules A, Habermehl D, von Nettelbladt F, Debus J.

BMC Cancer. 2014 Feb 5;14:67. doi: 10.1186/1471-2407-14-67.

16.

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.

Konstan MW, Döring G, Heltshe SL, Lands LC, Hilliard KA, Koker P, Bhattacharya S, Staab A, Hamilton A; Investigators and Coordinators of BI Trial 543.45..

J Cyst Fibros. 2014 Mar;13(2):148-55. doi: 10.1016/j.jcf.2013.12.009. Epub 2014 Jan 17.

17.

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC.; ESCF Investigators..

Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2.

18.

Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.

Morgan WJ, Wagener JS, Yegin A, Pasta DJ, Millar SJ, Konstan MW; Scientific Advisory Group, investigators.; coordinators of the Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2013 Oct;163(4):1152-7.e2. doi: 10.1016/j.jpeds.2013.05.013. Epub 2013 Jun 27.

19.

CT-guided radiofrequency ablation of osteoid osteoma: correlation of clinical outcome and imaging features.

Rehnitz C, Sprengel SD, Lehner B, Ludwig K, Omlor G, Merle C, Kauczor HU, Ewerbeck V, Weber MA.

Diagn Interv Radiol. 2013 Jul-Aug;19(4):330-9. doi: 10.5152/dir.2013.096.

20.

[Evaluation of the sagittal profile in patients with thoracic adolescent idiopathic scoliosis Lenke type 1 following posterior correction].

Akbar M, Dreher T, Schwab F, Omlor G, Wang H, Bruckner T, Carstens C, Wiedenhöfer B.

Orthopade. 2013 Mar;42(3):150-6. doi: 10.1007/s00132-012-2060-2. German.

PMID:
23429997

Supplemental Content

Loading ...
Support Center